Creating models that meet decision makers' needs: A us payer perspective

Value in Health

Volumn 15, Issue 6, 2012, Pages 792-793

  Watkins, John B ^a  

^a Premera Blue Cross   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; EDITORIAL; HEALTH CARE SYSTEM; HUMAN; MODEL; PATENT; PRIORITY JOURNAL; UNITED STATES; VALIDATION PROCESS;

ADVISORY COMMITTEES; COMPARATIVE EFFECTIVENESS RESEARCH; DECISION SUPPORT SYSTEMS, CLINICAL; ECONOMICS, PHARMACEUTICAL; MANAGED CARE PROGRAMS; MODELS, ECONOMIC; REPRODUCIBILITY OF RESULTS; UNCERTAINTY; UNITED STATES;

EID: 84866364906     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.03.1386     Document Type: Editorial

References (6)

1. M.C. Weinstein, B. O'Brien, J. Hornberger Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices - modeling studies Value Health 6 2003 9 17
2. F. Clement, M.A. Harris, J.J. Li Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada JAMA 302 2009 1437 1443
3. J.J. Caro, A.H. Briggs, U. Siebert Modeling good research practices - overview: a report of the ISPOR-SMDM modeling good research practices task force-1 Value Health 15 2012 796 803
4. Patient-Centered Outcomes Research Institute What is patient-centered outcomes research? http://www.pcori.org/patient-centered-outcomes-research/ [Accessed February 19, 2012]
5. D.M. Eddy, W. Hollingworth, J.J. Caro Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7 Value Health 15 2012 843 850
6. P.J. Neumann, C.H. Fang, J.T. Cohen 30 Years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement Pharmacoeconomics 27 2009 861 872